Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex

The Pharmacogenomics Journal volume 7, pages 56–65 (2007)Cite this article

A Corrigendum to this article was published on 18 July 2006

Abstract

There is increasing evidence that polymorphisms of the adenosine 5′ triphosphate membrane transporters ABCB1 (P-glycoprotein, MDR1) may affect expression and function, whereas less information is available about the impact of ABCC2 (multidrug resistance-associated protein (MRP2)) single-nucleotide polymorphisms . Particularly, their role in human kidney for drug elimination and in the etiology of renal cell carcinoma is poorly understood. ABCB1 and ABCC2 mRNA and protein expression levels were determined by real-time polymerase chain reaction or immunohistochemistry in kidney cancer and adjacent unaffected cortex tissue of 82 nephrectomized renal cell cancer (RCC) patients (63 clear-cell RCC (CCRCC), 19 non-CCRCC). The DNA of all patients was genotyped for ABCB1 −2352G>A, −692T>C, 2677G>T/A (Ala893Ser/Thr), and 3435C>T, and ABCC2 −24C>T, 1249G>A (Val417Ile) and 3972C>T. ABCB1 and ABCC2 were less expressed in CCRCC than in normal cortex on mRNA as well as on protein level. Although the overall genotype frequency distribution did not differ between the patients and a matched control group, ABCB1 2677T/A and 3435T genotypes were associated with higher (P=0.02 and P=0.04) and ABCC2 −24 T with lower mRNA levels in normal tissues (0.03). The expression of ABCB1 and ABCC2 was not related to genetic variants in RCC tissue. In a reporter gene assay in HepG2 cells, the ABCC2 −24T construct showed an 18.7% reduced activity (P=0.003). In conclusion, ABCB1 and ABCC2 genotypes modulate the expression in the unaffected renal cortex of RCC patients, possibly contributing to inter-individual differences in drug and xenobiotics elimination. Their role in RCC cancer susceptibility or chemotherapy resistance needs further elucidation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

Abbreviations

5′-UTR:

5′-untranslated region

ABC:

adenosine 5′ triphosphate-binding cassette

MDR1:

multidrug resistance protein 1

MRP2:

multidrug resistance-associated protein

P-gp:

P-glycoprotein

SNP:

single-nucleotide polymorphism

PCR/RFLP:

polymerase chain reaction/restriction fragment length polymorphism

References

  1. Borst P, Evers R, Kool M, Wijnholds J . The multidrug resistance protein family. Biochim Biophys Acta 1999; 1461: 347–357.

    Article  CAS  Google Scholar 

  2. Klein I, Sarkadi B, Varadi A . An inventory of the human ABC proteins. Biochim Biophys Acta 1999; 1461: 237–262.

    Article  CAS  Google Scholar 

  3. Konig J, Nies AT, Cui Y, Leier I, Keppler D . Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochim Biophys Acta 1999; 1461: 377–394.

    Article  CAS  Google Scholar 

  4. Young AM, Allen CE, Audus KL . Efflux transporters of the human placenta. Adv Drug Deliv Rev 2003; 55: 125–132.

    Article  CAS  Google Scholar 

  5. Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM . Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 1999; 39: 361–398.

    Article  CAS  Google Scholar 

  6. Schaub TP, Kartenbeck J, Konig J, Vogel O, Witzgall R, Kriz W et al. Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules. J Am Soc Nephrol 1997; 8: 1213–1221.

    CAS  PubMed  Google Scholar 

  7. Schaub TP, Kartenbeck J, Konig J, Spring H, Dorsam J, Staehler G et al. Expression of the MRP2 gene-encoded conjugate export pump in human kidney proximal tubules and in renal cell carcinoma. J Am Soc Nephrol 1999; 10: 1159–1169.

    CAS  PubMed  Google Scholar 

  8. Cui Y, Konig J, Buchholz JK, Spring H, Leier I, Keppler D . Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. Mol Pharmacol 1999; 55: 929–937.

    CAS  Google Scholar 

  9. Juliano RL, Ling V . A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 1976; 455: 152–162.

    Article  CAS  Google Scholar 

  10. Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmoller J, Johne A et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 2000; 97: 3473–3478.

    Article  CAS  Google Scholar 

  11. Johne A, Kopke K, Gerloff T, Mai I, Rietbrock S, Meisel C et al. Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene. Clin Pharmacol Ther 2002; 72: 584–594.

    Article  CAS  Google Scholar 

  12. Verstuyft C, Schwab M, Schaeffeler E, Kerb R, Brinkmann U, Jaillon P et al. Digoxin pharmacokinetics and MDR1 genetic polymorphisms. Eur J Clin Pharmacol 2003; 58: 809–812.

    Article  CAS  Google Scholar 

  13. Wang D, Johnson AD, Papp AC, Kroetz DL, Sadee W . Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability. Pharmacogenet Genom 2005; 15: 693–704.

    Article  CAS  Google Scholar 

  14. Uwai Y, Masuda S, Goto M, Motohashi H, Saito H, Okuda M et al. Common single nucleotide polymorphisms of the MDR1 gene have no influence on its mRNA expression level of normal kidney cortex and renal cell carcinoma in Japanese nephrectomized patients. J Hum Genet 2004; 49: 40–45.

    Article  CAS  Google Scholar 

  15. Siegsmund M, Brinkmann U, Schaffeler E, Weirich G, Schwab M, Eichelbaum M et al. Association of the P-glycoprotein transporter MDR1(C3435T) polymorphism with the susceptibility to renal epithelial tumors. J Am Soc Nephrol 2002; 13: 1847–1854.

    Article  CAS  Google Scholar 

  16. Motzer RJ, Bander NH, Nanus DM . Renal-cell carcinoma. N Engl J Med 1996; 335: 865–875.

    Article  CAS  Google Scholar 

  17. Storkel S, van den BE . Morphological classification of renal cancer. World J Urol 1995; 13: 153–158.

    Article  CAS  Google Scholar 

  18. Brauch H, Weirich G, Hornauer MA, Storkel S, Wohl T, Bruning T . Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma. J Natl Cancer Inst 1999; 91: 854–861.

    Article  CAS  Google Scholar 

  19. Bruning T, Weirich G, Hornauer MA, Hofler H, Brauch H . Renal cell carcinomas in trichloroethene (TRI) exposed persons are associated with somatic mutations in the von Hippel–Lindau (VHL) tumour suppressor gene. Arch Toxicol 1997; 71: 332–335.

    Article  CAS  Google Scholar 

  20. Dhote R, Pellicer-Coeuret M, Thiounn N, Debre B, Vidal-Trecan G . Risk factors for adult renal cell carcinoma: a systematic review and implications for prevention. BJU Int 2000; 86: 20–27.

    Article  CAS  Google Scholar 

  21. Cascorbi I, Gerloff T, Johne A, Meisel C, Hoffmeyer S, Schwab M et al. Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin Pharmacol Ther 2001; 69: 169–174.

    Article  CAS  Google Scholar 

  22. Taniguchi S, Mochida Y, Uchiumi T, Tahira T, Hayashi K, Takagi K et al. Genetic polymorphism at the 5′ regulatory region of multidrug resistance 1 (MDR1) and its association with interindividual variation of expression level in the colon. Mol Cancer Ther 2003; 2: 1351–1359.

    CAS  PubMed  Google Scholar 

  23. Meissner K, Sperker B, Karsten C, Zu Schwabedissen HM, Seeland U, Bohm M et al. Expression and localization of P-glycoprotein in human heart: effects of cardiomyopathy. J Histochem Cytochem 2002; 50: 1351–1356.

    Article  CAS  Google Scholar 

  24. Vogelgesang S, Kunert-Keil C, Cascorbi I, Mosyagin I, Schroder E, Runge U et al. Expression of multidrug transporters in dysembryoplastic neuroepithelial tumors causing intractable epilepsy. Clin Neuropathol 2004; 23: 223–231.

    CAS  PubMed  Google Scholar 

  25. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3: RESEARCH0034.1–RESEARCH0034.11.

    Article  Google Scholar 

  26. Terwilliger JDaOJ . Handbook of Human Genetic Linkage. Johns Hopkins University Press: Baltimore, MD, 1994.

    Google Scholar 

  27. Ernest S, Rajaraman S, Megyesi J, Bello-Reuss EN . Expression of MDR1 (multidrug resistance) gene and its protein in normal human kidney. Nephron 1997; 77: 284–289.

    Article  CAS  Google Scholar 

  28. Maher JM, Cheng X, Slitt AL, Dieter MZ, Klaassen CD . Induction of the multidrug resistance-associated protein family of transporters by chemical activators of receptor-mediated pathways in mouse liver. Drug Metab Dispos 2005; 33: 956–962.

    Article  CAS  Google Scholar 

  29. Miller DS . Xenobiotic export pumps, endothelin signaling, and tubular nephrotoxicants – a case of molecular hijacking. J Biochem Mol Toxicol 2002; 16: 121–127.

    Article  CAS  Google Scholar 

  30. Bauer B, Hartz AM, Fricker G, Miller DS . Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood–brain barrier. Mol Pharmacol 2004; 66: 413–419.

    CAS  PubMed  Google Scholar 

  31. Denson LA, Auld KL, Schiek DS, McClure MH, Mangelsdorf DJ, Karpen SJ . Interleukin-1beta suppresses retinoid transactivation of two hepatic transporter genes involved in bile formation. J Biol Chem 2000; 275: 8835–8843.

    Article  CAS  Google Scholar 

  32. Miller DS, Sussman CR, Renfro JL . Protein kinase C regulation of p-glycoprotein-mediated xenobiotic secretion in renal proximal tubule. Am J Physiol 1998; 275: F785–F795.

    CAS  PubMed  Google Scholar 

  33. Kovacs G, Fuzesi L, Emanual A, Kung HF . Cytogenetics of papillary renal cell tumors. Genes Chromosome Cancer 1991; 3: 249–255.

    Article  CAS  Google Scholar 

  34. Siegmund W, Ludwig K, Giessmann T, Dazert P, Schroeder E, Sperker B et al. The effects of the human MDR1 genotype on the expression of duodenal P-glycoprotein and disposition of the probe drug talinolol. Clin Pharmacol Ther 2002; 72: 572–583.

    Article  CAS  Google Scholar 

  35. Meissner K, Jedlitschky G, Meyer zu SH, Dazert P, Eckel L, Vogelgesang S et al. Modulation of multidrug resistance P-glycoprotein 1 (ABCB1) expression in human heart by hereditary polymorphisms. Pharmacogenetics 2004; 14: 381–385.

    Article  CAS  Google Scholar 

  36. Nakamura T, Sakaeda T, Horinouchi M, Tamura T, Aoyama N, Shirakawa T et al. Effect of the mutation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects. Clin Pharmacol Ther 2002; 71: 297–303.

    Article  CAS  Google Scholar 

  37. Day DA, Tuite MF . Post-transcriptional gene regulatory mechanisms in eukaryotes: an overview. J Endocrinol 1998; 157: 361–371.

    Article  CAS  Google Scholar 

  38. Petriz J, Gottesman MM, Aran JM . An MDR-EGFP gene fusion allows for direct cellular localization, function and stability assessment of P-glycoprotein. Curr Drug Deliv 2004; 1: 43–56.

    Article  CAS  Google Scholar 

  39. Fellay J, Marzolini C, Meaden ER, Back DJ, Buclin T, Chave JP et al. Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study. Lancet 2002; 359: 30–36.

    Article  CAS  Google Scholar 

  40. Hitzl M, Drescher S, van der KH, Schaffeler E, Fischer J, Schwab M et al. The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells. Pharmacogenetics 2001; 11: 293–298.

    Article  CAS  Google Scholar 

  41. Kim RB . MDR1 single nucleotide polymorphisms: multiplicity of haplotypes and functional consequences. Pharmacogenetics 2002; 12: 425–427.

    Article  CAS  Google Scholar 

  42. Kim RB, Leake BF, Choo EF, Dresser GK, Kubba SV, Schwarz UI et al. Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin Pharmacol Ther 2001; 70: 189–199.

    Article  CAS  Google Scholar 

  43. Ito S, Ieiri I, Tanabe M, Suzuki A, Higuchi S, Otsubo K . Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects. Pharmacogenetics 2001; 11: 175–184.

    Article  CAS  Google Scholar 

  44. Itoda M, Saito Y, Soyama A, Saeki M, Murayama N, Ishida S et al. Polymorphisms in the ABCC2 (cMOAT/MRP2) gene found in 72 established cell lines derived from Japanese individuals: an association between single nucleotide polymorphisms in the 5′-untranslated region and exon 28. Drug Metab Dispos 2002; 30: 363–364.

    Article  CAS  Google Scholar 

  45. Popowski K, Sperker B, Kroemer HK, John U, Laule M, Stangl K et al. Functional significance of a hereditary adenine insertion variant in the 5′-UTR of the endothelin-1 gene. Pharmacogenetics 2003; 13: 445–451.

    Article  CAS  Google Scholar 

  46. Geier A, Mertens PR, Gerloff T, Dietrich CG, En-Nia A, Kullak-Ublick GA et al. Constitutive rat multidrug-resistance protein 2 gene transcription is down-regulated by Y-box protein 1. Biochem Biophys Res Commun 2003; 309: 612–618.

    Article  CAS  Google Scholar 

  47. del Moral RG, Olmo A, Aguilar M, O'Valle F . P glycoprotein: a new mechanism to control drug-induced nephrotoxicity. Exp Nephrol 1998; 6: 89–97.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The skilful technical assistance of Ingrid Geissler is gratefully acknowledged. We also thank Dr Amke Caliebe and Professor Michael Krawczak, Institute of Medical Informatics and Statistics, UKSH Campus Kiel, Germany, for valuable statistical advice. This work was supported by the German Federal Ministry for Education and Research (01 ZZ 0103).

Author information

Authors and Affiliations

  1. Institute of Pharmacology, University Hospital Schleswig-Holstein, Kiel, Germany

    S Haenisch, C J Wruck & I Cascorbi

  2. Department of Urology, University of Greifswald, Greifswald, Germany

    U Zimmermann

  3. Institute of Pathology, University of Greifswald, Greifswald, Germany

    E Dazert & R W Warzok

  4. Institute of Pharmacology, University of Greifswald, Greifswald, Germany

    S Haenisch, P Dazert, S Siegmund, H K Kroemer & I Cascorbi

Authors
  1. S Haenisch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. U Zimmermann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E Dazert
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C J Wruck
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P Dazert
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S Siegmund
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H K Kroemer
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. R W Warzok
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. I Cascorbi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to I Cascorbi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Haenisch, S., Zimmermann, U., Dazert, E. et al. Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex. Pharmacogenomics J 7, 56–65 (2007). https://doi.org/10.1038/sj.tpj.6500403

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.tpj.6500403

Keywords

This article is cited by

Search

Advanced search

Quick links